First evidence of a delay-dependent working memory-enhancing effect of modafinil in mice
暂无分享,去创建一个
A. Célérier | C. Piérard | D. Béracochéa | M. Pérès | J. Le Merrer | D Béracochéa | B Cagnard | A Célérier | J le Merrer | M Pérès | C Piérard | Barbara Cagnard
[1] L. Garma,et al. Modafinil in obstructive sleep apnea-hypopnea syndrome: a pilot study in 6 patients. , 1997, Respiration; international review of thoracic diseases.
[2] K. Fuxe,et al. Effects of the vigilance promoting drug modafinil on the synthesis of GABA and glutamate in slices of rat hypothalamus , 1999, Neuroscience Letters.
[3] J. Bizot. Effects of Various Drugs Including Organophosphorus Compounds (OPC) and Therapeutic Compounds Against OPC on DRL Responding , 1998, Pharmacology Biochemistry and Behavior.
[4] K. Fuxe,et al. The antinarcoleptic drug modafinil increases glutamate release in thalamic areas and hippocampus , 1997, Neuroreport.
[5] S. Nicolaidis,et al. Nonamphetamine awakening agent modafinil induces feeding changes in the rat , 1993, Brain Research Bulletin.
[6] K. Montgomery. A test of two explanations of spontaneous alternation. , 1952, Journal of comparative and physiological psychology.
[7] D. Batejat,et al. Disrupted Sleep-Wake Rhythm and Performance: Advantages of Modafinil , 1995 .
[8] J. O’Keefe. Hippocampal function: does the working memory hypothesis work? Should we retire the cognitive map theory? , 1979 .
[9] D. Batéjat,et al. Interest of modafinil, a new psychostimulant, during a sixty‐hour sleep deprivation experiment , 1995, Fundamental & clinical pharmacology.
[10] M. Jouvet,et al. ネコ脳のアンフェタミン,メチルフェニデート,モダフィニルの覚醒作用における標的ニューロンのc‐fos免疫組織化学による検索 , 1996 .
[11] F. Rambert,et al. Central alpha 1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animals. , 1990, European journal of pharmacology.
[12] C. Piérard,et al. Effects of a vigilance-enhancing drug, modafinil, on rat brain metabolism: 2D COSY 1H-NMR study , 1995, Brain Research.
[13] J. Baranski,et al. Modafinil, d‐amphetamine and placebo during 64 hours of sustained mental work. I. Effects on mood, fatigue, cognitive performance and body temperature , 1995, Journal of sleep research.
[14] E. Bullmore,et al. Functional magnetic resonance imaging neuroactivation studies in normal subjects and subjects with the narcoleptic syndrome. Actions of modafinil , 1999, Journal of sleep research.
[15] D. Béracochéa,et al. Effects of Ibotenic Lesions of Mammillary Bodies on Spontaneous and Rewarded Spatial Alternation in Mice , 1990, Journal of Cognitive Neuroscience.
[16] M. Jouvet,et al. Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil , 1988, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[17] M. Spedding,et al. Contrasting EEG profiles elicited by antipsychotic agents in the prefrontal cortex of the conscious rat: antagonism of the effects of clozapine by modafinil , 1999, British journal of pharmacology.
[18] P. Contreras,et al. Brain regional substrates for the actions of the novel wake-promoting agent modafinil in the rat: comparison with amphetamine , 1998, Neuroscience.
[19] M. Jouvet,et al. Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat. , 1996, Proceedings of the National Academy of Sciences of the United States of America.